| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Drugs Made In America Acquisition II Corp. (DMII) has 6 insiders with recent SEC Form 4 filings, including 2 buys and 2 sells. DMII is classified in the Diversified Financial Services industry within the Financials sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 15.07M | $150.60M | - | |
| 10% | 15.07M | $150.60M | - | |
| Dir | 100.0K | $999.0K | - | |
| CFO | 100.0K | $999.0K | - | |
| Dir | 100.0K | $999.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2025 | Stockwell Lynn | CEO And Exe. Chair Of Board | Sell | 7,966,667 | $0.00 | - | -54.3% | |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | 10% Owner | Sell | 7,966,667 | $0.00 | - | -54.3% | |
| Sep 26, 2025 | Stockwell Lynn | CEO And Exe. Chair Of Board | Buy | 700,000 | $0.00 | - | +4.9% | |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | 10% Owner | Buy | 700,000 | $0.00 | - | +4.9% |